| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 2,882,400 | | Cost of Revenue | 1,079,800 | | | Gross Profit | 1,802,600 | | | Operating Expenses | | Research Development | 72,800 | | Selling General and Administrative | 1,021,000 | | Non Recurring | 13,100 | | Others |
-
| | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 695,700 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| | Earnings Before Interest And Taxes | 695,700 | | Interest Expense | 43,300 | | Income Before Tax | 652,400 | | Income Tax Expense | 251,400 | | Minority Interest | (7,100) | | | | Net Income From Continuing Ops | 393,900 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 393,900 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $393,900 |
|
0.46% Nasdaq 
Income Statement
